JW (CAYMAN) THERAPEUTICS CO. LTD
(HKEX: 2126)
JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company was founded by Yi Ping Li on September 6, 2017 and is headquartered in Shanghai, China.
2.420 -
-0.060
(-2.42%)
Range
2.400 - 2.520
(5%)
Open
2.480
Previous Close
2.480
Bid Price
2.420
Bid Volume
('000)
25.5
Ask Price
2.450
Ask Volume
('000)
29.5
Volume
('000)
720
Value
1,767,890
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
